Protagonist Therapeutics (PTGX)

• Market cap: $6.38B
• 1 day: -2.55%
• 5 days: -5.19%
• 1 month: -0.39%
• 3 months: 21.51%
• 6 months: 33.58%
• Year to date: 14.71%
• 1 year: 122.97%
• 5 years: 237.38%
• 10 years: 754.7%
• Sector: Healthcare
• Industry: Biotechnology

About: Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Employees: 132